Ahmad Jabrodini

Dr. Ahmad Jabrodini


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2025 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
FAFatemeh Amirinia
Fatemeh Amirinia
AJAhmad Jabrodini
Ahmad Jabrodini
HMHamid Morovati
Hamid Morovati
PAPegah Ardi
Pegah Ardi
MMMarjan Motamedi
Marjan Motamedi
β-glucans area part of the fungal cell wall structure, mainly considered a potential therapeutic and diagnostic tool for invasive fungal infections (IFIs) (1). Several studies have been conducted about their effects on health. They have been reported to reduce blood glucose and have a strong inhibitory effect on lipid peroxidation as a regulator of blood

25 August 2023 in Journal of Medical Microbiology
Verified
Journal Article
Open access
AJAhmad Jabrodini
Ahmad Jabrodini
MSMaryam Sohrabizdeh
Maryam Sohrabizdeh
SAShima Aboutalebian
Shima Aboutalebian
SHSeyed Basir Hashemi
Seyed Basir Hashemi
KZKamiar Zomorodian
Kamiar Zomorodian
MMMarjan Motamedi
Marjan Motamedi
Introduction. Otomycosis is a superficial fungal infection that is responsible for approximately 9–27 % of otitis externa. However, fungal communities in otomycosis are varied, but Aspergillus spp. and Candida spp. are the most common causes of this infection. Hypothesis Statement. The multiplex PCR assay is postulated to be able to directly detect more than one fungal genus in cerumen specimens. Aim. This study aimed to develop and evaluate the role of the multiplex PCR assay in detecting the most common genus of fungi that cause otomycosis directly from the cerumen specimens. Methodology. To detect Candida and Aspergillus/Penicillium genera, three pairs of primers, including pan-fungal, pan-Candida, and pan-Aspergillus/Penicillium, were used in a multiplex PCR. In order to evaluate the performance and reproducibility of the multiplex PCR. the cerumen of 140 patients suspected of otomycosis were investigated. Results. Pan-Candida and pan-Aspergillus/Penicillium primers were designed to amplify the ITS1–5.8S–ITS2 region and the β-tubulin gene, respectively. In the multiplex PCR assay, 64 (47.40 %) and 118 (87.40 %) specimens were positive with pan-Candida and pan-Aspergillus/Penicillium primers, respectively. Double amplicon bands of Candida and Aspergillus were obtained in 51 (37.77 %) specimens. In the culture method, yeast (n=18, 13.33 %) and mould (n=117, 86.66 %) were isolated from 135 cerumen specimens. The sensitivity, specificity, and positive and negative predictive values of the multiplex PCR assays using culture method results as the gold standard were determined to be 94, 33, 97, and 22 %, respectively. Conclusion. In our study, multiplex PCR assays enabled simultaneous detection of two common genera of the causative agent of otomycosis in a cerumen specimen. Regarding the high sensitivity of the first step of the multiplex PCR assay, this assay may be used for the direct detection of Candida and Aspergillus genera in other clinical specimens.

1 January 2025 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
FAFatemeh Amirinia
Fatemeh Amirinia
MMMarjan Motamedi
Marjan Motamedi
PAPegah Ardi
Pegah Ardi
AJAhmad Jabrodini
Ahmad Jabrodini
Oral cavity cancers, especially oral squamous cell carcinoma (OSCC), are a major subset of head and neck malignancies. Increasing evidence indicates that oral microbiota, particularly Candida albicans ( C. albicans ), plays a significant role in OSCC development and progression. While C. albicans is normally a commensal organism in the human microbiome, it can become pathogenic under certain conditions. The carcinogenic potential of C. albicans contributes to oral cancer by acting both as a co‐factor and a direct pathogen. This involves complex interactions with the host immune system and the expression of multiple virulence factors. The dynamic relationship between C. albicans and its host influences disease outcomes and cancer progression. This review focuses on key virulence mechanisms of C. albicans , including adhesion to host cells, secretion of hydrolytic enzymes, production of carcinogenic metabolites, induction of chronic inflammation, and release of candidalysin, a cytolytic peptide toxin. Understanding these factors is essential to clarify how C. albicans promotes OSCC initiation and progression. Improved knowledge of C. albicans virulence may lead to targeted therapies, preventive strategies, and novel biomarkers for early detection, ultimately enhancing treatment outcomes and prognosis for patients with oral cavity cancers.

19 November 2024 in Journal of Medical Mycology
Verified
Journal Article
Closed access
SYSomayeh Yazdanpanah
Somayeh Yazdanpanah
MSMojtaba shafiekhani
Mojtaba shafiekhani
ZZZahra Zare
Zahra Zare
HNHamed Nikoupour
Hamed Nikoupour
BGBita Geramizadeh
Bita Geramizadeh
KZKamiar Zomorodian
Kamiar Zomorodian

6 May 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
MMMarjan Motamedi
Marjan Motamedi
NSNiloofar Shaabani
Niloofar Shaabani
AJAhmad Jabrodini
Ahmad Jabrodini
MSMojtaba shafiekhani
Mojtaba shafiekhani
SYSomayeh Yazdanpanah
Somayeh Yazdanpanah
NANeda Amirzadeh
Neda Amirzadeh
Candiduria, defined as the presence of Candida spp. in urine, is more common among hospitalized patients, particularly those admitted to intensive care units (ICUs). This study aimed to determine the epidemiology, associated risk factors, clinical symptoms, ultrasound findings, and outcomes of empirical antifungal therapy in neonates, infants, and pediatric patients with symptomatic candiduria admitted to neonatal ICU (NICU) and pediatric ICU (PICU) in southern Iran. In this retrospective cross-sectional study, medical records of neonates, infants, and pediatric patients with candiduria admitted to the NICU and PICU of two tertiary-care hospitals in Shiraz, Iran, between March 2012 and March 2022 were reviewed. Data were extracted from the hospital information system. Among 19,900 ICU admissions (3,471 neonates; 4,810 infants; and 11,619 pediatric patients), 400 patients (2.01%) were diagnosed with candiduria. The prevalence was 2.18% (n = 76) in neonates, 1.58% (n = 76) in infants, and 2.13% (n = 248) in pediatric patients. Prematurity was the most common risk factor among neonates (29, 38.15%), whereas urinary catheterization was predominant in infants (41, 53.94%) and history of bacterial urinary tract infection in pediatric patients (165, 66.53%). Hydronephrosis (176, 44%) was the most frequent ultrasound finding. Most patients had an ICU stay of 1-5 days (335, 83.75%), and candiduria was typically diagnosed within the first three days of ICU admission. Fluconazole was the primary empirical antifungal agent, while amphotericin B was administered in selected cases. All patients achieved complete clinical and microbiological resolution following treatment. Our findings indicate that history of bacterial urinary tract infection, urinary catheterization, antibiotic exposure, poor feeding, and hydronephrosis are important predisposing factors for candiduria in critically ill neonates, infants, and pediatric patients. Fluconazole appears to be an effective first-line empirical therapy in this population.

1 March 2022 in Armaghane Danesh
Verified
Journal Article
Open access
PDF file
AJAhmad Jabrodini
Ahmad Jabrodini
STSf Taghavi
Sf Taghavi
FHF Heidari
F Heidari
Background & aim: About 40% of women and 12% of men experience a urinary tract infection at least once in their lifetime. Aminoglycosides are very effective antimicrobial agents. The emergence and spread of antibiotic resistance in Escherichia coli (E. coli) is becoming a global public health concern. The aim of this study ...